undefined undefined
NaN.000
NaN.00%
Kiniksa Pharmaceuticals press release (NASDAQ:KNSA): Q1 GAAP EPS of -$0.25 misses by $0.09. Revenue of $79.86M (+65.2% Y/Y) beats by $1.4M. As of March 31, 2024, Kiniksa had $213.6 million of cash, ca...
04-23 19:37
– ARCALYST (rilonacept) 2023 net product revenue grew ~90% year-over-year to $2...
01-04 20:30
HAMILTON, Bermuda, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, L...
01-03 05:01
HAMILTON, Bermuda, July 17, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, L...
2023-07-17 20:00